<bill session="103" type="h" number="3552" updated="2010-04-19T08:24:31-04:00">
	<state datetime="1993-11-19">REFERRED</state>
	<status><introduced datetime="1993-11-19"/></status>

	<introduced datetime="1993-11-19"/>
	<titles>
		<title type="official" as="introduced">Respecting market exclusivity for certain drugs.</title>
	</titles>
	<sponsor id="402763"/>
	<cosponsors>
		<cosponsor id="400604" joined="1993-11-22"/>
	</cosponsors>
	<actions>
		<action datetime="1993-11-19"><text>Referred to the House Committee on Energy and Commerce.</text></action>
		<action datetime="1993-11-20"><text>Sponsor introductory remarks on measure. (CR E2980)</text></action>
		<action datetime="1993-12-03"><committee name="House Committee on Energy and Commerce"/><text>Referred to the Subcommittee on Health and the Environment.</text></action>
	</actions>
	<committees>
		<committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee" />
		<committee code="" name="House Energy and Commerce" subcommittee="Health and Environment" activity="Referral" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Drugs"/>
		<term name="Business"/>
		<term name="Drug industry"/>
		<term name="Government information"/>
		<term name="Government paperwork"/>
		<term name="Medicine"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	11/19/1993--Introduced.
Amends the Federal Food, Drug, and Cosmetic Act to extend the market exclusivity for a drug which meets the requirements of this Act.

	</summary>
</bill>
